CTL2 Inhibitors
CTL2 inhibitors, also known as carnitine acylcarnitine translocase 2 inhibitors, represent a class of compounds that target a specific molecular player in cellular metabolism. At the heart of this chemical class lies the carnitine acylcarnitine translocase 2 (CTL2) enzyme, a key protein involved in the transport of fatty acids across the mitochondrial inner membrane. Mitochondria play a pivotal role in cellular energy production, and the CTL2 enzyme facilitates the movement of long-chain fatty acids into the mitochondria for beta-oxidation, a process central to energy generation. By inhibiting CTL2, these compounds modulate the transport of fatty acids, potentially influencing the delicate balance of energy homeostasis within the cell.
The significance of CTL2 inhibitors extends beyond their immediate impact on fatty acid transport. The regulation of fatty acid metabolism is intricately linked to broader cellular processes, including lipid biosynthesis, energy storage, and overall metabolic flux. As such, the modulation of CTL2 activity by inhibitors may have far-reaching effects on cellular physiology. Understanding the structural and biochemical properties of CTL2 inhibitors is crucial for unraveling the intricate details of their mode of action and assessing their potential implications for cellular function. Researchers are actively investigating the structural determinants of CTL2 inhibition and the consequences of disrupting fatty acid transport, shedding light on the potential applications of CTL2 inhibitors in various fields of cellular and molecular biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Ibuprofen non-selectively inhibits COX-1 and COX-2, decreasing the synthesis of pro-inflammatory prostaglandins. | ||||||
Naproxen | 22204-53-1 | sc-200506 sc-200506A | 1 g 5 g | $24.00 $41.00 | ||
Naproxen is a non-selective COX inhibitor, similar to ibuprofen, with a longer duration of action. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Aspirin irreversibly inhibits COX-1 and modifies the COX-2 enzyme to reduce the formation of inflammatory prostaglandins. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Indomethacin is a potent inhibitor of both COX-1 and COX-2, leading to a significant reduction in prostaglandin synthesis. | ||||||
Meloxicam | 71125-38-7 | sc-200626 sc-200626A sc-200626B | 20 mg 100 mg 500 mg | $36.00 $94.00 $156.00 | 3 | |
Meloxicam preferentially inhibits COX-2, which is less likely to cause gastrointestinal side effects compared to non-selective COX inhibitors. | ||||||
Piroxicam | 36322-90-4 | sc-200576 sc-200576A | 1 g 5 g | $109.00 $376.00 | 2 | |
Piroxicam is a long-acting non-selective COX inhibitor with anti-inflammatory properties. | ||||||
Diclofenac acid | 15307-86-5 | sc-357332 sc-357332A | 5 g 25 g | $109.00 $298.00 | 5 | |
Diclofenac acid is a non-selective COX inhibitor with pronounced anti-inflammatory and analgesic effects. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Sulindac is a prodrug that is metabolized to an active sulfide compound that non-selectively inhibits COX. | ||||||
Etodolac | 41340-25-4 | sc-204747 sc-204747A | 100 mg 250 mg | $89.00 $131.00 | 1 | |
Etodolac selectively inhibits COX-2, which makes it less likely to cause gastrointestinal disturbances. | ||||||
Vioxx | 162011-90-7 | sc-208486 | 100 mg | $190.00 | 3 | |
Vioxx is a selective COX-2 inhibitor that was withdrawn from the market due to safety concerns, but it effectively inhibits prostaglandin synthesis associated with inflammation when it was available. | ||||||